Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × ribociclib × 30 days × Clear all

Sponsor

Conditions

Breast Neoplasms 20 Neoplasm Metastasis 3 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Solid Tumors 1 Lung Neoplasms 1 Locoregional Recurrence 1 HR+/HER2- Breast Cancer 1 HER2 Negative Breast Cancer Not Immediately Operated 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Digestive System Neoplasms 1 Continued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Malignancies 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms, Male 1 Anatomic Stage II Breast Cancer AJCC v8 1 Advanced Breast Cancer 1

Interventions

Bevacizumab 16 lenvatinib 11 atezolizumab 10 Specimen Handling 10 Nivolumab 10 durvalumab 9 Magnetic Resonance Spectroscopy 8 tremelimumab 6 sintilimab 6 Ipilimumab 6 pembrolizumab 5 tislelizumab 4 regorafenib 4 fludarabine 3 cabozantinib 3 X-Rays 3 Radiosurgery 3 Immunotherapy 3 Immunoglobulin G 3 Ethiodized Oil 3 Disulfides 3 Cyclophosphamide 3 sapanisertib 2 Sunitinib 2 Radiotherapy 2 Radiofrequency Ablation 2 Radiation 2 Oxaliplatin 2 Biopsy 2 ulixertinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡